Daptomycin induced acute eosinophilic pneumonia is a rare and potentially life threatening condition characterized by rapid respiratory failure, pulmonary infiltrates and eosinophilia. Risk factors for acute eosinophilic pneumonia include smoking, environmental irritants or inhalants and certain medications such as Daptomycin [1]. In this review of literature, we aim to explore the potential triggers for developing acute eosinophilic pneumonia in patients exposed to Daptomycin. The exact immune mechanism for daptomycin induced AEP is unknown, however the current proposed mechanism describes a T helper 2 lymphocyte response to inactivated daptomycin in the pulmonary surfactant, which leads to eosinophilia. Disordered T regulatory cell function is seen in patients with certain cancers, allergies and autoimmune conditions. We propose that patients with these underlying risk factors may be at increased risk of developing AEP after becoming exposed to Daptomycin. Understanding potential risk factors is crucial for health care workers as it allows them to identify susceptible populations, explore preventative measures and treat accordingly.
References
[1]
Philit, F., Etienne-Mastroïanni, B., Parrot, A., Guérin, C., Robert, D. and Cordier, J. (2002) Idiopathic Acute Eosinophilic Pneumonia: A Study of 22 Patients. A Multicenter Study. American Journal of Respiratory and Critical Care Medicine, 166, 1235-1239. https://doi.org/10.1164/rccm.2112056
[2]
Desch, A.N., Henson, P.M. and Jakubzick, C.V. (2012) Pulmonary Dendritic Cell Development and Antigen Acquisition. Immunologic Research, 55, 178-186. https://doi.org/10.1007/s12026-012-8359-6
[3]
Justiz Vaillant, A.A., Modi, P. and Jan, A. (2024) Atopy. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK542187/
[4]
Barrie, A., Mourabet, M.E., Weyant, K., Clarke, K., Gajendran, M., Rivers, C., et al. (2012) Recurrent Blood Eosinophilia in Ulcerative Colitis Is Associated with Severe Disease and Primary Sclerosing Cholangitis. Digestive Diseases and Sciences, 58, 222-228. https://doi.org/10.1007/s10620-012-2329-7
[5]
Portalatin, G.M., Chin, J., Foster, B., Perry, K. and McWilliams, C. (2021) Daptomycin-Induced Acute Eosinophilic Pneumonia. Cureus, 13, e13509. https://doi.org/10.7759/cureus.13509
[6]
Somoza-Cano, F.J., Makadia, A., Cruz-Peralta, M.P., Zakarna, L., Demyda, E., Al Armashi, A.R., et al. (2021) Acute Eosinophilic Pneumonia Secondary to Daptomycin. Cureus, 13, e19403. https://doi.org/10.7759/cureus.19403
[7]
Kumar, S., Acosta-Sanchez, I. and Rajagopalan, N. (2018) Daptomycin-Induced Acute Eosinophilic Pneumonia. Cureus, 10, e2899. https://doi.org/10.7759/cureus.2899
[8]
Raman, V., Chaudhary, I. and Shieh, S. (2021) Eosinophilic Pneumonia: A Case of Daptomycin Induced Lung Injury. Journal of Community Hospital Internal Medicine Perspectives, 11, 280-285. https://doi.org/10.1080/20009666.2021.1883813
[9]
Nickerson, M., Bhargava, A. and Kale-Pradhan, P. (2017) Daptomycin-Associated Eosinophilic Pneumonia with Rechallenge: A Case Report. The International Journal of Clinical Pharmacology and Therapeutics, 55, 521-524. https://doi.org/10.5414/cp202952
[10]
Valaiyapathi, R., Wu, M. and McGregor, A. (2022) Ground Glass Opacities Are Not Always COVID-19: A Case of Acute Eosinophilic Pneumonitis Caused by Daptomycin. The Lancet, 399, 270. https://doi.org/10.1016/s0140-6736(22)00009-5
[11]
Storandt, M.H. and Matta, A. (2020) Acute Eosinophilic Pneumonia: A Rare Complication of Daptomycin Therapy. Cureus, 12, e6803. https://doi.org/10.7759/cureus.6803
[12]
Rachid, M., Ahmad, K., Saunders-Kurban, M., Fatima, A., Shah, A. and Nahhas, A. (2017) Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery. Case Reports in Pulmonology, 2017, Article ID: 8525789. https://doi.org/10.1155/2017/8525789
[13]
Abd Algayoum, R., Elsherif, A., Khan, Z.H. and Roman, G. (2022) Daptomycin-Induced Eosinophilic Pneumonia Mimicking Multifocal Pneumonia. Cureus, 14, e30521. https://doi.org/10.7759/cureus.30521
[14]
Raza, A., Arslan, A., Atiq, M.U., Chan, V. and Patel, R.K. (2019) Unexpected Outcome of Daptomycin-Induced Eosinophilic Pneumonia: Rarity within a Rarity. Cureus, 11, e6271. https://doi.org/10.7759/cureus.6271
[15]
Allen, J.N. and Davis, W.B. (1994) Eosinophilic Lung Diseases. American Journal of Respiratory and Critical Care Medicine, 150, 1423-1438. https://doi.org/10.1164/ajrccm.150.5.7952571
[16]
Tazelaar, H.D., Linz, L.J., Colby, T.V., Myers, J.L. and Limper, A.H. (1997) Acute Eosinophilic Pneumonia: Histopathologic Findings in Nine Patients. American Journal of Respiratory and Critical Care Medicine, 155, 296-302. https://doi.org/10.1164/ajrccm.155.1.9001328
[17]
Chaaban, T. (2020) Acute Eosinophilic Pneumonia Associated with Non-Cigarette Smoking Products: A Systematic Review. Advances in Respiratory Medicine, 88, 142-146. https://doi.org/10.5603/arm.2020.0088
[18]
Rubin, B.K. (2002) Physiology of Airway Mucus Clearance. Respiratory Care, 47, 761-768.
[19]
West, K.A., Sheeti, A., Tamura MacKay, K. and Forrest, G.N. (2022) Eosinophilic Syndromes Associated with Daptomycin Use: Re-Exposure Hypersensitivity Pneumonitis and Prior Peripheral Eosinophilia. Open Forum Infectious Diseases, 9, ofac065. https://doi.org/10.1093/ofid/ofac065
[20]
Rajendiran, A. and Tenbrock, K. (2021) Regulatory T Cell Function in Autoimmune Disease. Journal of Translational Autoimmunity, 4, Article ID: 100130. https://doi.org/10.1016/j.jtauto.2021.100130
[21]
Vignali, D.A.A., Collison, L.W. and Workman, C.J. (2008) How Regulatory T Cells Work. Nature Reviews Immunology, 8, 523-532. https://doi.org/10.1038/nri2343
[22]
Winterberg, P.D. and Ford, M.L. (2017) The Effect of Chronic Kidney Disease on T Cell Alloimmunity. Current Opinion in Organ Transplantation, 22, 22-28. https://doi.org/10.1097/mot.0000000000000375
[23]
Raj, A.A., Birring, S.S., Green, R., Grant, A., de Caestecker, J. and Pavord, I.D. (2008) Prevalence of Inflammatory Bowel Disease in Patients with Airways Disease. Respiratory Medicine, 102, 780-785. https://doi.org/10.1016/j.rmed.2007.08.014
[24]
Elkoshi, Z. (2022) Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites? Frontiers in Immunology, 13, Article ID: 821598. https://doi.org/10.3389/fimmu.2022.821598
